Where does Galvani Bioelectronics Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Galvani Bioelectronics Limited ranks #5,283 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Galvani Bioelectronics Limited hold?

Galvani Bioelectronics Limited holds 65 US utility patents granted between 2019 and 2025, spanning 15 technology areas.

What is Galvani Bioelectronics Limited's Innovation Score?

Galvani Bioelectronics Limited has an Innovation Score of 56.5 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Galvani Bioelectronics Limited focus on?

Galvani Bioelectronics Limited's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 51 patents, ranking #74 of 1,943 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Galvani Bioelectronics Limited's patent grant rate increasing or decreasing?

Galvani Bioelectronics Limited's recent grant velocity is +2850% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Galvani Bioelectronics Limited's patents?

Galvani Bioelectronics Limited's patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Galvani Bioelectronics Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Galvani Bioelectronics Limited

USPTO PatentsView assignee record - 65 granted patents across 15 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Galvani ranks #5,283 of 49,997 tracked US assignees by granted-patent volume, with 65 patents across 15 technology areas.

#5,283
of 49,997 US assignees by volume: Top 6%
by Innovation Score (56.5/100): 13.9
avg claims per patent: +2850%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5283 · Foreign Corporation #5,283 · 65 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 65 grants
UPPER-Q #5,283/49,997
PHOTO-FINISH Envision Aesc Japan
CPC-FOCUS A61N · 15 areas
INNOV-PAR 56.5/100
CLAIMS-RICH 13.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +2850% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Envision Aesc Japan Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Galvani’s 56.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.5 pts (26%) Velocity 20.0 pts (35%) Breadth 13.7 pts (24%) Claim depth 8.4 pts (15%)

Qualcomm Incorporated · highest

85
Vitro Flat Glass · near

57
Cepheid · near

57
Futaijing Precision… · near

57
Galvani Bioelectronics · this assignee

57
State Grid of China · near

57
3D Lighting… · lowest

7

What this shows Galvani's Innovation Score is 56.5/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Galvani?

Each dot is one of Galvani’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Galvani’s own 13.9 claims/patent is ABOVE the 10.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Galvani vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Galvani's grants concentrate

Galvani Bioelectronics Limited is a focused PatentsView assignee: 15 CPC subclasses with 78.5% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2023 (23 grants) versus a trough of 2 in 2019. By volume, Galvani sits between Envision Aesc Japan Ltd. and Hisense Co., Ltd..

Galvani's three-year grant acceleration

Galvani Bioelectronics Limited shows 49 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Envision Aesc Jap…

65
Evapco

65
Fuji Seal Interna…

65
Foxlink Image Tec…

65
Graco Children's…

65
Gachon University…

65
Glaukos

65
Hisense

65
Galvani Bioelectr… ◀

65

What this shows Galvani holds 65 patents at rank #5,282, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Galvani

By rank, the assignees closest to #5,282 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Galvani's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Galvani, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Galvani ranks #74 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

Cepheid 57 State Grid Corporation of China 57 Futaijing Precision Electronics (Yantai) Co., Ltd. 57 Vitro Flat Glass LLC 57

Similar claim depth

Nearest assignees by average claims per patent (13.9 here).

McLaren Automotive Limited 13.9 avg Hisense Electric Co., Ltd. 13.9 avg Johnson Electric S.A. 13.9 avg Hitachi Chemical Company, Ltd. 13.9 avg

Galvani's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Galvani Bioelectronics Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	3.1%
2020	2	3.1%
2021	8	12.3%
2022	13	20.0%
2023	23	35.4%
2024	13	20.0%
2025partial year	4	6.2%

Which technologies does Galvani Bioelectronics Limited patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 51

A61B - DIAGNOSIS; SURGERY; Identification 28

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

H04B - Transmission 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G21H - Obtaining Energy From Radioactive SOURCES; Applications OF Radiation From Radioactive Sources, NOT Otherwise Provided FOR; Utilising Cosmic Radiation 1

H02H - Emergency Protective Circuit Arrangements 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Galvani Bioelectronics Limited's patent record in context - here's where to go next.

Galvani Bioelectronics Limited's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 78.5% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #5,283 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Galvani Bioelectronics Limited against Envision Aesc Japan Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 56.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.